Riparian Pharmaceuticals Competitors and Similar CompaniesClear all
Riparian Pharmaceuticals's competitors and similar companies include GBT (Global Blood Therapeutics), Albireo Pharma, ICB International and Albumedix.
 Riparian Pharmaceuticals Riparian Pharmaceuticals is a biotechnology company engaged in discovering therapeutics to promote vascular health. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Albireo Pharma Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases. |  ICB International ICB International (ICBI) is a company that provides disease altering therapies for afflictions of the central nervous system. |  Albumedix Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases. | |
Founding Date | Founding Date 2012 | Founding Date 2012 | Founding Date 2003 | Founding Date 2008 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Watertown, US HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Boston, US HQ Göteborg, SE | Locations San Diego, US HQ | Locations Nottinghamshire, GB HQ Nottingham, GB |
Employees | Employees 233% decrease | Employees 352106% increase | Employees 5541% increase | Employees 11 | Employees 871% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 915.9 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $40.6m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) £26.1m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods $1.4m (FY, 2021) | Cost of goods N/A | Cost of goods N/A |
Net income | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income ($34m) (FY, 2021) | Net income N/A | Net income £5m (FY, 2018) |
Funding | |||||
Latest funding round | Latest funding round $ 500k (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 895k (about 13 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 3.5m | Total funding raised $ 88.7m | Total funding raised $ 40m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyAlbireo Pharma
HQ
Boston, US
Employees
55↑ 41% increase
Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.
View companyICB International
HQ
San Diego, US
Employees
11
ICB International (ICBI) is a company that provides disease altering therapies for afflictions of the central nervous system.
View companyAlbumedix
HQ
Nottinghamshire, GB
Employees
87↑ 1% increase
Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.
View company